FDA Adverse Event Injury Summary report: N

ENDURANT BIFURCATED STENT GRAFT SYSTEM

MDR report key: 2181395 · Received July 21, 2011

Report

Report Number
2953200-2011-01306
Event Type
Injury
Date Received
July 21, 2011
Date of Event
June 16, 2011
Report Date
June 21, 2011
Manufacturer
MEDTRONIC CARDIOVASCULAR IRELAND
Product Code
MIH
PMA / PMN Number
P100021
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
ND, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVALUATION, RESULTS: (OCCLUSION). RESULTS AND CONCLUSIONS: (NARROWING IN THE DISTAL AORTIC NECK).

Description of Event or Problem · 1

AN ENDURANT ABDOMINAL STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF AN ABDOMINAL AORTIC ANEURYSM APPROXIMATELY SEVEN WEEKS AGO. THE ANEURYSM AND VESSEL MORPHOLOGY WERE REPORTED AS A NARROWING IN THE DISTAL AORTIC NECK. THE GRAFT WAS IMPLANTED WITH A 180 DEGREE LIMB ORIENTATION, AS PLANNED. IT WAS REPORTED THAT THE PATIENT CAME IN WITH A LEFT LIMB OCCLUSION, APPROXIMATELY ONE MONTH AGO, WHICH REQUIRED LYTIC THERAPY AND SUBSEQUENT STENTING OF THE ENDOGRAFT LIMB (REF MFR. # 2953200-2011-01306). AFTER ANOTHER MANUFACTURER'S STENT WAS IMPLANTED IN THE LEFT LIMB, THE RIGHT LIMB SUBSEQUENTLY OCCLUDED (REF MFR. # 2953200-2011-01307), AS THE PHYSICIAN DID NOT PERFORM THE KISSING BALLOON TECHNIQUE. THE RIGHT LIMB OCCLUSION WAS RESOLVED WITH BALLOONING AND THE BLOOD FLOW WAS RESTORED. INTERNAL REVIEW OF A SINGLE STILL ANGIOGRAPHIC IMAGE AT IMPLANT, SHOWS THE LIMBS PATENT AND CROSSED, WITH POSSIBLE BUNCHING OF FABRIC AT THE IPSILATERAL LIMB, WHERE IT CROSSES (LIKELY NEAR THE AORTIC BIFURCATION). POST-IMPLANT FILMS SHOW THE LEFT LIMB OCCLUDED BEGINNING AT THE FLOW DIVIDER; THE RIGHT LIMB APPEARS PATENT. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED, AND THE PATIENT IS FINE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDURANT BIFURCATED STENT GRAFT SYSTEM MIH MEDTRONIC CARDIOVASCULAR IRELAND NA V00853375

Patients

Seq Age Sex Outcome Treatment
1 75 YR Required Intervention